Pharmaceutical companies that manufacture insulin made headlines last year when they voluntarily agreed to provide discount cards that lower the monthly cost of insulin for many people to $35.
Chinese cell therapy biotech developing TIL therapies raises $60M Series B
Grit Biotechnology said Friday that it closed a Series B, raising more than $60 million from several Chinese investors. The financing came from several new
September 9, 2023